Stem cells have long been a topic of interest around the globe. Now and
then, stem cells are being studied for revealing their beneficial effects. Countries
around the world are in a race in stem cell research. Stem cells possess some unique
and considerable qualities that hardly any other cell to date has. The outbreak of novel
coronavirus or coronavirus disease-19 (COVID-19) was located in Wuhan, China.
After a few months, the episode was declared Pandemic by the World Health
Organization (WHO) as it engulfed many countries worldwide. Since then, stem cells
have gained more push in clinical as well as pre-clinical stage research studies.
COVID-19 shares some molecular properties with other coronaviruses like severe
acute respiratory syndrome (SARS) and the Middle East respiratory syndrome
(MERS). Stem cells surprisingly showed some good outcomes in many patients
infected with COVID-19. A lot of laboratory evaluation is being carried out to check
the feasibility of different stem cells to be used in COVID-19 infected patients. This
chapter discusses and highlights the possible interventions in COVID-19 using
different lineages and bio-cultured stem cells.
Keywords: Bone marrow, Coronavirus, Cytokines, Hematopoietic, Mesenchymal,
Patients, SARS-CoV-2, Stem cells.
